Häftad, Engelska, 2027
1 868 kr
Kommande
Therapeutic Horizons in NSCLC: AI-Driven Innovations in Diagnosis and Treatment explores how artificial intelligence transforms the diagnosis and management of non-small cell lung cancer (NSCLC). The book offers an interdisciplinary overview of NSCLC biology, diagnostics, and therapeutic strategies, emphasizing AI and machine learning applications. It covers molecular pathogenesis, biomarkers, personalized therapies, and cutting-edge AI-driven tools integrated into clinical workflows. The content provides insights into global clinical practices, emerging precision medicine approaches, and innovative AI techniques such as predictive modeling and genomic data integration. It aims to bridge the gap between technological advances and clinical application, offering practical guidance for implementation. The book also addresses disparities in NSCLC care and promotes equitable, data-driven solutions for improved patient outcomes. This resource benefits clinicians, researchers, and data scientists by enhancing understanding of AI’s role in early detection, targeted therapies, and prognosis. It equips readers with actionable knowledge to translate AI innovations into real-world clinical and research settings, fostering collaboration across disciplines.Provides a detailed overview of AI and machine learning applications in NSCLC diagnostics and therapeuticsIntegrates molecular biology, clinical workflows, and technological innovations for a translational approachHighlights global perspectives, disparities, and ethical considerations in AI-driven lung cancer management